Piper Sandler has initiated coverage on Heartflow Inc (HTFL) with an Overweight rating, marking the firm's first assessment of the company's investment potential. Headquartered in Mountain View, California, Heartflow operates in the health care industry, focusing on diagnosing coronary artery diseases. The company's innovative HeartFlow Platform utilizes AI and advanced computational fluid dynamics to create personalized three-dimensional models of patients' hearts based on a single coronary computed tomography angiography (CCTA). This technology includes features such as Roadmap Analysis and FFRCT Analysis, which assist physicians in delivering precision care to patients with coronary artery disease (CAD).
As of September 1, 2025, Heartflow's shares are trading at $26.86, with a market capitalization of $2.4 billion. The company recently reported disappointing earnings, with a Q3 2025 EPS of $-0.35, falling short of the expected $-0.22, reflecting a 56.0% surprise. Looking ahead, Heartflow is set to announce its next earnings report on November 12, 2025, with an EPS estimate of $-0.22 and revenue expectations of $42.8 million.
Analyst ratings, such as the one from Piper Sandler, provide insights based on extensive research and financial modeling. However, these assessments are subject to change as new information becomes available. Investors are encouraged to consider a range of factors, including company fundamentals and industry trends, when making decisions. As of November 1, 2025, the analyst consensus for Heartflow includes 3 Strong Buy, 6 Buy, and 2 Hold ratings, indicating a general bullish sentiment among analysts.